Related Experiment Videos
Dexfenfluramine in psychotic patients
13rd Medical Clinic, 1st Medical Faculty, Charles University, Prague, Czech Republic.
The International Journal of Eating Disorders
|September 19, 1998
Summary
Dexfenfluramine effectively treated severe overeating in three psychotic patients. This medication managed binge eating without worsening psychiatric symptoms, even in complex cases.
Area of Science:
- Pharmacology
- Psychiatry
- Endocrinology
Background:
- Dexfenfluramine (DF) is contraindicated in patients with severe psychiatric disorders.
- Severe overeating can co-occur with chronic psychosis, presenting complex treatment challenges.
Observation:
- Three patients with chronic psychosis and severe overeating were treated with dexfenfluramine (DF).
- Psychiatric pharmacotherapy remained unchanged during DF administration.
- Patients included those with paranoid schizophrenic psychosis and mixed psychosis.
Findings:
- Overeating was resolved in all three patients without adverse effects on their psychotic states.
- Body weight was maintained by all patients.
- Two patients with poorly controlled diabetes showed significant metabolic improvements.
- Dosage of up to 75 mg/day was required in one patient during binge eating episodes.
Implications:
- Dexfenfluramine (DF) may be a viable treatment for severe overeating in select psychotic patients.
- Close psychiatric supervision is crucial when using DF in this population.
- Further research is warranted to explore the efficacy and safety of DF in psychotic patients with eating disorders.